Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sandercock

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Stroke|December 4, 2010
Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort studyWilliam Whiteley, Caroline Jackson, Steff Lewis, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
The NeuroGrid stroke exemplar clinical trial protocolJ M Wardlaw, Philip Bath, Peter Sandercock, et al.
Stroke|December 6, 2014
Sensitivity and specificity of the hyperdense artery sign for arterial obstruction in acute ischemic strokeGrant Mair, Elena V Boyd, Francesca M Chappell, et al.
Lancet (London, England)|September 6, 2005
International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusionAndrew J Molyneux, Richard S C Kerr, Ly-Mee Yu, et al.
Stroke|April 24, 2004
Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costsPeter Sandercock, Eivind Berge, Martin Dennis, et al.
Stroke|June 25, 2015
Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc AnalysisPooja Khatri, Darren Tayama, Geoff Cohen, et al.
Stroke|October 25, 2011
The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic strokeWilliam Whiteley, Joanna Wardlaw, Martin Dennis, et al.
BMJ (Clinical Research Ed.)|September 3, 2008
Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trialJackie F Price, Marlene C Stewart, Ian J Deary, et al.
Health Technology Assessment (Winchester, England)|May 27, 2020
Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCTMartin Dennis, John Forbes, Catriona Graham, et al.
Health Technology Assessment (Winchester, England)|May 6, 2014
An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluationJoanna Wardlaw, Miriam Brazzelli, Hector Miranda, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Stroke|December 4, 2010
Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort studyWilliam Whiteley, Caroline Jackson, Steff Lewis, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
The NeuroGrid stroke exemplar clinical trial protocolJ M Wardlaw, Philip Bath, Peter Sandercock, et al.
Stroke|December 6, 2014
Sensitivity and specificity of the hyperdense artery sign for arterial obstruction in acute ischemic strokeGrant Mair, Elena V Boyd, Francesca M Chappell, et al.
Lancet (London, England)|September 6, 2005
International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusionAndrew J Molyneux, Richard S C Kerr, Ly-Mee Yu, et al.
Stroke|April 24, 2004
Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costsPeter Sandercock, Eivind Berge, Martin Dennis, et al.
Stroke|June 25, 2015
Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc AnalysisPooja Khatri, Darren Tayama, Geoff Cohen, et al.
Stroke|October 25, 2011
The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic strokeWilliam Whiteley, Joanna Wardlaw, Martin Dennis, et al.
BMJ (Clinical Research Ed.)|September 3, 2008
Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trialJackie F Price, Marlene C Stewart, Ian J Deary, et al.
Health Technology Assessment (Winchester, England)|May 27, 2020
Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCTMartin Dennis, John Forbes, Catriona Graham, et al.
Health Technology Assessment (Winchester, England)|May 6, 2014
An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluationJoanna Wardlaw, Miriam Brazzelli, Hector Miranda, et al.
Pageof 14